Cash flow, not top-line growth, has become the dividing line between cannabis operators that survive and those that quietly implode. Green Thumb Industries (OTC: GTBIF) posted first-quarter revenue of $300.2 million, up 7.4% year over year, but the number that matters more is $76 million in operating cash flow and $93.5 million in normalized EBITDA. The company also posted GAAP net income of $15.4 million - a rarity in a sector where profitability still isn't the norm.
What separates Green Thumb from the pack isn't just the income statement. It's the balance sheet. The company closed the quarter with roughly $344.5 million in cash and $289.9 million in total debt, a ratio that would look conservative in almost any regulated retail category, let alone one still operating under Section 280E. That financial cushion matters at the store level too - dispensary operators managing budroom inventory, wholesale menus, and compliance logs need working capital that doesn't evaporate the moment tax season hits. Back-end infrastructure plays into this as well; multi-state operators increasingly lean on integrated retail systems, including platforms built for specific state rules, such as cannabis POS for Massachusetts dispensaries, to keep seed-to-sale tracking and SKU management tight enough that shrinkage doesn't quietly eat margin. cannabis POS for Massachusetts dispensaries
Buybacks Signal Confidence, Not Just Optics
Rather than issuing new shares to fund expansion - the move that diluted so many cannabis shareholders into the ground over the past five years - Green Thumb has been buying its own stock back. It repurchased about 6 million shares for $33.3 million during the quarter, then added another 7.4 million shares afterward, pushing 2025 buybacks to nearly $78 million. That's a meaningful capital allocation decision, not a rounding error. It signals that management believes the business generates more cash than it needs for near-term growth, and that returning capital to shareholders won't compromise the balance sheet.
Selective Expansion Over Growth at Any Cost
Green Thumb now runs more than 110 Rise dispensaries nationally, with exposure to both medical and adult-use markets. New footholds in Minnesota and Texas reflect a pattern: expand where licensing and demographics justify it, not everywhere at once. That discipline stands in contrast to operators who chased license caps and social equity programs in every newly legal state, only to discover that wholesale pricing compression and lab testing costs made those stores unprofitable almost immediately.
The Federal Question Still Looms
None of this erases the structural pressure facing the industry. Section 280E still taxes cannabis companies on gross profit rather than net income, an enormous burden compared with any other regulated retail category. Pricing pressure in mature markets continues to squeeze margins, and federal legalization remains stalled in Washington with no clear timeline. Green Thumb's advantage is that it has built a profitable operation under current rules rather than betting the business on future reform.
- Operating cash flow and EBITDA matter more than revenue growth alone in assessing cannabis operators.
- Share buybacks, not dilution, indicate financial discipline and balance-sheet confidence.
- Selective market entry reduces exposure to oversaturated, price-compressed state markets.
- 280E remains a persistent tax burden regardless of operational performance.
Smaller, higher-risk operators may still offer sharper upside if federal policy shifts quickly. But for investors and operators watching how a cannabis business should actually be run - with real cash discipline, selective growth, and a balance sheet that can absorb shocks - Green Thumb offers a template that many multi-state operators still haven't matched.
